Breaking News Instant updates and real-time market news.

2022-06-21 17:11:23 FIS FIS $92.95 / +1.16 (+1.26%) 17:11 06/21/22 06/21 17:11 06/21/22 17:11	FIS files automatic mixed securities shelf

OTHER BREAKING NEWS FROM THE FLY

Options	Digital Turbine put volume heavy and directionally bearish » 11:35 08/11/22 08/11 11:35 08/11/22 11:35 APPS Digital Turbine $23.20 / -0.13 (-0.56%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options APPS Digital Turbine $23.20 / -0.13 (-0.56%) 06/29/22 Digital Turbine to replace Tivity Health in S&P 600 at open on 6/29 06/29/22 Portland General Electric to replace Digital Turbine in S&P 400 at open on 6/29 06/24/22 Digital Turbine to replace Tivity Health in S&P 600 at open on 6/29 06/24/22 Portland General Electric to replace Digital Turbine in S&P 400 at open on 6/29 APPS Digital Turbine $23.20 / -0.13 (-0.56%) 08/09/22 Craig-Hallum Digital Turbine price target lowered to $60 from $85 at Craig-Hallum 08/09/22 B. Riley Digital Turbine price target raised to $33 from $29 at B. Riley 06/29/22 B. Riley B. Riley starts 'mispriced' Digital Turbine with Buy, $29 price target 06/28/22 B. Riley Digital Turbine initiated with a Buy at B. Riley APPS Digital Turbine $23.20 / -0.13 (-0.56%) 08/08/22 Digital Turbine sees Q2 adjusted EPS 32-34c, consensus 37c 08/08/22 Digital Turbine reports Q1 adjusted EPS 38c, consensus 35c 05/31/22 Digital Turbine sees Q1 non-GAAP EPS 34c-35c, consensus 44c 05/31/22 Digital Turbine reports Q4 non-GAAP EPS 39c, consensus 39c APPS Digital Turbine $23.20 / -0.13 (-0.56%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Fly Intel: Pre-market Movers 05/31/22 Fly Intel: After-Hours Movers 08/30/22 Digital Turbine, Inc. APPS Digital Turbine $23.20 / -0.13 (-0.56%) 08/08/22 Digital Turbine options imply 17.4% move in share price post-earnings 08/02/22 Digital Turbine put volume heavy and directionally bearish 05/31/22 Digital Turbine options imply 14.6% move in share price post-earnings 05/16/22 Digital Turbine call volume above normal and directionally bullish
Recommendations	Trulieve Cannabis price target lowered to C$36.50 from C$40 at Stifel » 11:34 08/11/22 08/11 11:34 08/11/22 11:34 TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) Stifel analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) 03/22/22 Tilt appoints Lynn Ricci as VP, investor relations, corporate communications TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) 08:30 Today Craig-Hallum Trulieve Cannabis price target lowered to $32 from $40 at Craig-Hallum 07:39 Today Cowen Trulieve Cannabis price target lowered to $24 from $65 at Cowen 08/10/22 Alliance Global Partners Trulieve Cannabis price target lowered to C$35 from C$40 at Alliance Global Partners 07/22/22 Seaport Global Trulieve Cannabis initiated with a Buy at Seaport Global TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) 05/12/22 Trulieve Cannabis reiterates 2022 revenue view $1.3B-$1.4B 05/12/22 Trulieve Cannabis reports Q1 adjusted EPS 1c vs. 30c last year TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says TCNNF Trulieve Cannabis $12.92 / -0.36 (-2.71%) 08/04/22 Here's What You Missed in Cannabis This Week 07/28/22 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 07/22/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/21/22 Rising High: Exclusive talk with funding solutions provider FundCanna 09/13/22 Benzinga Cannabis Capital Conference
Recommendations	Kinaxis price target raised to C$235 from C$215 at Stifel » 11:34 08/11/22 08/11 11:34 08/11/22 11:34 KXSCF Kinaxis $133.05 / +10.2236 (+8.32%) Stifel analyst Suthan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $133.05 / +10.2236 (+8.32%) 05/09/22 BMO Capital Kinaxis price target lowered to C$185 from C$200 at BMO Capital 05/09/22 RBC Capital Kinaxis price target lowered to C$175 from C$200 at RBC Capital 05/09/22 TD Securities Kinaxis price target lowered to C$210 from C$230 at TD Securities 04/26/22 National Bank Kinaxis price target raised to C$250 from C$225 at National Bank
Recommendations	CubicFarm Systems price target lowered to C$0.70 from C$0.95 at Stifel » 11:33 08/11/22 08/11 11:33 08/11/22 11:33 CUBXF CubicFarm Systems / + Stifel analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CUBXF CubicFarm Systems / + 06/02/22 CubicFarm Systems closes C$10.6M overnight marketed offering CUBXF CubicFarm Systems / + 06/17/22 Raymond James CubicFarm downgraded to Market Perform from Outperform at Raymond James 06/16/22 Raymond James CubicFarm Systems price target lowered to C$1.10 from C$1.25 at Raymond James 06/06/22 Stifel CubicFarm Systems price target lowered to C$0.95 from C$1.10 at Stifel 05/18/22 Raymond James CubicFarm Systems price target lowered to C$1.25 from C$2 at Raymond James
Periodicals	Microsoft claims Sony pays developers to not put games on Game Pass, VGC says » 11:33 08/11/22 08/11 11:33 08/11/22 11:33 MSFT Microsoft $287.36 / -1.81 (-0.63%) , SONY Sony $86.00 / +0.63 (+0.74%) , ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) In a document sent to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options MSFT SONY ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 08/09/22 Barclays deploys Microsoft teams as collaboration platform 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/04/22 Atlassian names Microsoft's Joe Binz as new CFO 08/04/22 Microsoft tests Game Pass family plan in Colombia, Ireland SONY Sony $86.00 / +0.63 (+0.74%) 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/07/22 Fly Intel: Top five weekend stock stories 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD 07/28/22 Backbone introduces Backbone One PlayStation Edition for iPhone users ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD 07/25/22 NetEase launches Diablo Immortal in Chinese market on Android, iOS 07/21/22 Activision Blizzard workers stage walkout to 'end gender inequity' 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD MSFT SONY ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 08/08/22 B. Riley B. Riley thinks Globalstar's mystery satellite capacity customer is Apple 08/04/22 MKM Partners 8x8 initiated with a Neutral at MKM Partners 08/04/22 Deutsche Bank Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank 08/03/22 Craig-Hallum RingCentral price target lowered to $110 from $175 at Craig-Hallum SONY Sony $86.00 / +0.63 (+0.74%) 07/08/22 Macquarie Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie 07/05/22 Citi Sony downgraded to Neutral from Buy at Citi 05/18/22 Oppenheimer Sony price target lowered to $125 from $150 at Oppenheimer 04/13/22 CLSA Sony downgraded to Outperform from Buy at CLSA ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/04/22 Deutsche Bank Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank 07/25/22 MoffettNathanson Activision Blizzard upgraded to Outperform at MoffettNathanson 05/31/22 Benchmark Marcus, Imax, WWE added to entertainment top ideas list at Benchmark 05/06/22 Benchmark Playstudios could still be target as industry consolidates, says Benchmark MSFT SONY ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 07/26/22 Microsoft sees FY23 revenue growth in double digits, consensus $225.98B 07/26/22 Microsoft reports Q4 EPS $2.23, consensus $2.30 07/26/22 Notable companies reporting after market close 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 SONY Sony $86.00 / +0.63 (+0.74%) 07/29/22 Sony raises FY22 consolidated sales view Y11.5T from Y11.4T 07/29/22 Sony reports Q1 revenue Y2.31T vs. Y2.26T last year 05/10/22 Sony sees FY22 consolidated sales Y11.4T vs. Y9.921B in FY21 05/10/22 Sony reports FY21 revenue Y9.921B vs. Y8.998B last year ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/01/22 Activision Blizzard reports Q2 adjusted EPS 48c, consensus 48c 08/01/22 Notable companies reporting after market close 04/25/22 Activision Blizzard reports Q1 EPS 64c, consensus 70c MSFT SONY ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/09/22 Microsoft lays off staff in Modern Life Experiences business, TechCrunch says 08/09/22 Microsoft tells staff to rein in business expenses, WSJ reports 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says SONY Sony $86.00 / +0.63 (+0.74%) 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/01/22 Sony says Microsoft owning 'Call of Duty' could affect console choice, VGC says 07/26/22 'Star Wars: KOTOR' remake delayed indefinitely, Bloomberg reports ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/03/22 Activision Blizzard, NetEase drop Warcraft mobile game, Bloomberg says 08/01/22 Sony says Microsoft owning 'Call of Duty' could affect console choice, VGC says 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says MSFT SONY ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games 07/27/22 What You Missed On Wall Street On Wednesday SONY Sony $86.00 / +0.63 (+0.74%) 08/09/22 What You Missed This Week in Video Games 08/07/22 Box Office Battle: ‘Bullet Train’ wins weekend with $30.1M debut 08/02/22 What You Missed This Week in Video Games 07/31/22 Box Office Battle: ‘DC League of Super-Pets’ wins weekend with $23M debut ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed This Week in Video Games 08/02/22 What You Missed On Wall Street This Morning MSFT ATVI MSFT Microsoft $287.36 / -1.81 (-0.63%) 07/28/22 Notable open interest changes for July 28th 07/26/22 Microsoft options imply 4.7% move in share price post-earnings 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd ATVI Activision Blizzard $80.88 / -0.03 (-0.04%) 08/09/22 Activision Blizzard put volume heavy and directionally bearish 08/01/22 Activision Blizzard options imply 2.6% move in share price post-earnings 05/02/22 Unusually active option classes on open May 2nd 04/25/22 Unusually active option classes on open April 25th
Recommendations	Bonterra Energy price target lowered to C$12 from C$13.75 at Stifel » 11:32 08/11/22 08/11 11:32 08/11/22 11:32 BNEFF Bonterra Energy $6.97 / +0.34 (+5.13%) Stifel analyst Cody Kwong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BNEFF Bonterra Energy $6.97 / +0.34 (+5.13%) 06/30/22 Stifel Bonterra Energy price target lowered to C$13.75 from C$14 at Stifel 06/01/22 Stifel Bonterra Energy price target raised to C$14 from C$13.75 at Stifel 05/11/22 Stifel Bonterra Energy price target raised to C$13.75 from C$12.50 at Stifel 03/11/22 Raymond James Bonterra Energy price target raised to C$10 from C$9 at Raymond James
Recommendations	Bird Construction price target lowered to C$9 from C$9.50 at Stifel » 11:32 08/11/22 08/11 11:32 08/11/22 11:32 BIRDF Bird Construction $5.46 / -0.008 (-0.15%) Stifel analyst Ian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BIRDF Bird Construction $5.46 / -0.008 (-0.15%) 08/08/22 TD Securities Bird Construction downgraded to Hold from Buy at TD Securities 08/04/22 Canaccord Bird Construction price target lowered to C$10 from C$13 at Canaccord 08/02/22 Industrial Alliance Bird Construction downgraded to Hold from Buy at Industrial Alliance 07/19/22 Raymond James IBI Group downgraded to Market Perform from Outperform at Raymond James
Recommendations	Andlauer Healthcare price target raised to C$65 from C$55 at Stifel » 11:31 08/11/22 08/11 11:31 08/11/22 11:31 ANDHF Andlauer Healthcare $37.80 / + (+0.00%) Stifel analyst Maggie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ANDHF Andlauer Healthcare $37.80 / + (+0.00%) 11:25 Today Scotiabank Andlauer Healthcare price target raised to C$57 from C$54 at Scotiabank 07/12/22 National Bank Andlauer Healthcare upgraded to Outperform from Sector Perform at National Bank 05/06/22 RBC Capital Andlauer Healthcare price target lowered to C$48 from C$52 at RBC Capital 05/06/22 National Bank Andlauer Healthcare price target raised to C$50 from C$49.50 at National Bank
Conference/Events	Jefferies fitness analyst to hold an analyst/industry conference call » 11:30 08/11/22 08/11 11:30 08/11/22 11:30 Fitness Analyst Konik,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Telus price target raised to C$34 from C$33.50 at Scotiabank » 11:30 08/11/22 08/11 11:30 08/11/22 11:30 TU Telus $23.43 / +0.385 (+1.67%) Scotiabank analyst Maher… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings TU Telus $23.43 / +0.385 (+1.67%) 08/04/22 LifeWorks shareholders vote in favor of arrangement resolution with Telus 07/26/22 TELUS Agriculture expands to TELUS Agriculture & Consumer Goods 07/06/22 Telus provides 2M Canadians with access to digital person health record 07/05/22 Telus investing $23B across Ontario from 2022 to 2026 TU Telus $23.43 / +0.385 (+1.67%) 08/08/22 TD Securities Telus price target raised to C$34 from C$33 at TD Securities 08/08/22 TD Securities Rogers Communications raised to Action List Buy at TD after recent weakness 06/28/22 Scotiabank Telus assumed with an Outperform at Scotiabank (yesterday) 06/17/22 BMO Capital Telus price target lowered to C$36 from C$37 at BMO Capital TU Telus $23.43 / +0.385 (+1.67%) 08/05/22 Telus reports Q2 EPS C$0.32 vs. C$0.26 a year ago 05/06/22 Telus backs FY22 operating revenue, adjusted EBITDA growth of 8%-10% 05/06/22 Telus reports Q1 adjusted basic EPS C$0.30 vs. C$0.27 a year ago

Recommendations	Superior Plus price target lowered to C$12.50 from C$13 at Scotiabank » 11:30 08/11/22 08/11 11:30 08/11/22 11:30 SUUIF Superior Plus $8.73 / -0.0749 (-0.85%) Scotiabank analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SUUIF Superior Plus $8.73 / -0.0749 (-0.85%) 05/16/22 Canaccord Superior Plus price target raised to C$14 from C$13.50 at Canaccord 05/12/22 Scotiabank Superior Plus price target lowered to C$13 from C$14 at Scotiabank 04/08/22 Raymond James Superior Plus price target lowered to C$13 from C$14 at Raymond James 04/08/22 TD Securities Superior Plus price target lowered to C$15.50 from C$16 at TD Securities
Recommendations	Stella-Jones price target lowered to C$50 from C$56 at Scotiabank » 11:29 08/11/22 08/11 11:29 08/11/22 11:29 STLJF Stella-Jones $29.81 / +0.22 (+0.74%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings STLJF Stella-Jones $29.81 / +0.22 (+0.74%) 08/10/22 Stella-Jones 'remains confident' in three-year strategic guidance 05/11/22 Stella-Jones comments on long-term guidance 03/09/22 Stella-Jones expects to return C$500M-C$600M to shareholders in 2022-2024 period 03/09/22 Stella-Jones raises quarterly dividend 11% to C$0.20 per share STLJF Stella-Jones $29.81 / +0.22 (+0.74%) 07/13/22 National Bank Stella-Jones price target lowered to C$51 from C$57 at National Bank 06/24/22 TD Securities Stella-Jones downgraded to Buy from Action List Buy at TD Securities 05/12/22 RBC Capital Stella-Jones price target lowered to C$40 from C$43 at RBC Capital 05/12/22 TD Securities Stella-Jones price target lowered to C$50 from C$56 at TD Securities STLJF Stella-Jones $29.81 / +0.22 (+0.74%) 08/10/22 Stella-Jones reports Q2 EPS C$1.51 vs. C$1.76 last year 05/11/22 Stella-Jones reports Q1 EPS C$0.73 vs. C$0.85 last year 03/09/22 Stella-Jones reports Q4 EPS C$0.34 vs. C$0.52 last year
Recommendations	Linamar price target raised to C$85 from C$80 at Scotiabank » 11:29 08/11/22 08/11 11:29 08/11/22 11:29 LIMAF Linamar $47.13 / +0.894 (+1.93%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LIMAF Linamar $47.13 / +0.894 (+1.93%) 07/22/22 CIBC Linamar price target lowered to C$85 from C$90 at CIBC 05/12/22 TD Securities Linamar price target lowered to C$80 from C$83 at TD Securities 04/25/22 CIBC Linamar price target lowered to C$85 from C$90 at CIBC 03/10/22 Scotiabank Linamar price target lowered to C$90 from C$105 at Scotiabank
Recommendations	High Liner Foods price target raised to C$16 from C$14 at Scotiabank » 11:28 08/11/22 08/11 11:28 08/11/22 11:28 HLNFF High Liner Foods $10.83 / +1.18 (+12.23%) Scotiabank analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HLNFF High Liner Foods $10.83 / +1.18 (+12.23%) 05/12/22 RBC Capital High Liner Foods price target lowered to C$13 from C$15 at RBC Capital 03/03/22 BMO Capital High Liner Foods price target lowered to C$16 from C$18 at BMO Capital 02/24/22 Scotiabank High Liner Foods price target lowered to C$14 from C$15.50 at Scotiabank 02/24/22 RBC Capital High Liner Foods price target lowered to C$15 from C$16 at RBC Capital
Recommendations	Element Fleet price target raised to C$17.50 from C$16 at Scotiabank » 11:28 08/11/22 08/11 11:28 08/11/22 11:28 ELEEF Element Fleet $11.88 / +0.285 (+2.46%) Scotiabank analyst Phil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ELEEF Element Fleet $11.88 / +0.285 (+2.46%) 04/19/22 Element Fleet releases 2022 ESG report 02/24/22 Element Fleet launches Arc by Element ELEEF Element Fleet $11.88 / +0.285 (+2.46%) 07:10 Today BMO Capital Element Fleet upgraded to Outperform from Market Perform at BMO Capital 05/11/22 Scotiabank Element Fleet price target raised to C$16 from C$15.50 at Scotiabank 05/11/22 CIBC Element Fleet upgraded to Outperformer from Neutral at CIBC 05/10/22 BMO Capital Element Fleet price target lowered to C$13.50 from C$14.50 at BMO Capital
Recommendations	Equitable Group price target lowered to C$79 from C$80 at Scotiabank » 11:27 08/11/22 08/11 11:27 08/11/22 11:27 EQGPF Equitable Group $43.38 / -1.235 (-2.77%) Scotiabank analyst Meny… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EQGPF Equitable Group $43.38 / -1.235 (-2.77%) 08/10/22 RBC Capital Equitable Group price target lowered to C$74 from C$75 at RBC Capital 08/10/22 National Bank Equitable Group price target lowered to C$73 from C$75 at National Bank 07/27/22 National Bank Equitable Group price target lowered to C$75 from C$86 at National Bank 05/12/22 BMO Capital Equitable Group price target lowered to C$91 from C$97 at BMO Capital
Recommendations	Dexterra Group price target lowered to C$8 from C$10 at Scotiabank » 11:27 08/11/22 08/11 11:27 08/11/22 11:27 HZNOF Dexterra Group $4.63 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HZNOF Dexterra Group $4.63 / + (+0.00%) 11:21 Today National Bank Dexterra Group price target lowered to C$10.50 from C$12 at National Bank 07/05/22 Raymond James Dexterra Group downgraded to Market Perform from Outperform at Raymond James 05/12/22 Scotiabank Dexterra Group price target lowered to C$10 from C$11 at Scotiabank 05/12/22 Raymond James Dexterra downgraded to Outperform from Strong Buy at Raymond James
Recommendations	CAE price target lowered to C$37.50 from C$43.50 at Scotiabank » 11:26 08/11/22 08/11 11:26 08/11/22 11:26 CAE CAE $20.75 / -0.7 (-3.26%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CAE CAE $20.75 / -0.7 (-3.26%) 08/10/22 CAE falls -14.0% 08/10/22 CAE falls -12.1% 08/10/22 CAE lowers FY23 consolidated adjusted segment operating income growth view 07/19/22 CAE launches electric aircraft modification program with Piper Aircraft CAE CAE $20.75 / -0.7 (-3.26%) 06/23/22 RBC Capital CAE assumed with an Outperform at RBC Capital 06/08/22 BMO Capital CAE price target lowered to C$42 from C$45 at BMO Capital 06/08/22 Scotiabank CAE price target raised to C$43.50 from C$43 at Scotiabank 06/06/22 BofA CAE upgraded to Neutral from Underperform at BofA CAE CAE $20.75 / -0.7 (-3.26%) 08/10/22 CAE reports Q1 adjusted EPS C$0.06 vs. C$0.19 a year ago 05/31/22 CAE sees FY23 Capital Expenditures $250M 05/31/22 CAE reports Q4 adjustedd EPS 29c, consensus 18c
Recommendations	Boyd Group Services price target raised to C$215 from C$200 at Scotiabank » 11:26 08/11/22 08/11 11:26 08/11/22 11:26 BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) 07:24 Today National Bank Boyd Group Services downgraded to Sector Perform from Outperform at National Bank 07:02 Today Stifel Boyd Group Services upgraded to Buy from Hold at Stifel 07/25/22 RBC Capital Boyd Group Services assumed with an Outperform at RBC Capital 07/22/22 CIBC Boyd Group Services price target lowered to C$175 from C$180 at CIBC
Recommendations	Argonaut Gold price target lowered to C$1.15 from C$1.25 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ARNGF Argonaut Gold / + Scotiabank analyst Ovais… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARNGF Argonaut Gold / + 08/02/22 Stifel Argonaut Gold price target lowered to C$1.50 from C$3.50 at Stifel 07/07/22 Desjardins Argonaut Gold price target lowered to C$1.25 from C$2.50 at Desjardins 07/07/22 BMO Capital Argonaut Gold resumed with an Outperform rating at BMO Capital 07/06/22 Scotiabank Argonaut Gold price target lowered to C$1.25 from C$3.00 at Scotiabank

Recommendations	Andlauer Healthcare price target raised to C$57 from C$54 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ANDHF Andlauer Healthcare $37.80 / + (+0.00%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ANDHF Andlauer Healthcare $37.80 / + (+0.00%) 07/12/22 National Bank Andlauer Healthcare upgraded to Outperform from Sector Perform at National Bank 05/06/22 RBC Capital Andlauer Healthcare price target lowered to C$48 from C$52 at RBC Capital 05/06/22 National Bank Andlauer Healthcare price target raised to C$50 from C$49.50 at National Bank 05/06/22 TD Securities Andlauer Healthcare price target lowered to C$54 from C$56 at TD Securities
Options	Lemonade call volume above normal and directionally bullish » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 LMND Lemonade $31.14 / +2.5 (+8.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/01/22 Lemonade sells Metromile's Enterprise Business Solutions platform to EIS 05/10/22 Lemonade trading resumes LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Oppenheimer Lemonade price target raised to $35 from $30 at Oppenheimer 08/10/22 Barclays Lemonade price target raised to $28 from $20 at Barclays 07/18/22 Piper Sandler Lemonade downgraded to Neutral from Overweight at Piper Sandler 05/11/22 Oppenheimer Lemonade price target lowered to $30 from $45 at Oppenheimer LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade raises FY22 revenue view to $236M-$239M, consensus $213.41M 08/08/22 Lemonade sees Q3 revenue $63M-$65M, consensus $56.97M 08/08/22 Lemonade reports Q2 EPS ($1.10), consensus ($1.32) 05/09/22 Lemonade sees FY22 revenue $205M-$208M, consensus $216.49M LMND Lemonade $31.14 / +2.5 (+8.73%) 02/14/22 Socially conscious sock maker Bombas exploring IPO, Bloomberg says LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Fly Intel: After-Hours Movers 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 06/25/22 Short Report: Bears undeterred by bounce in growth names 02/23/22 Fly Intel: After-Hours Movers LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Lemonade call volume above normal and directionally bullish 08/08/22 Lemonade options imply 12.1% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names 06/14/22 Largest borrow rate increases among liquid names
Recommendations	American Hotel Income Properties price target lowered to C$4.50 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) Scotiabank analyst Mario… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) 11:20 Today National Bank American Hotel Income Properties price target raised to C$4 at National Bank 05/18/22 National Bank American Hotel Income Properties price target lowered to C$4.75 at National Bank 05/12/22 Scotiabank American Hotel Income price target lowered to C$4.75 from C$5 at Scotiabank 03/10/22 National Bank American Hotel Income Properties price target raised to C$5 at National Bank
Recommendations	ATS Automation price target raised to C$60 from C$55 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) 05/20/22 Scotiabank ATS Automation price target raised to C$55 from C$53 at Scotiabank 05/20/22 TD Securities ATS Automation price target raised to C$52 from C$51 at TD Securities 05/20/22 National Bank ATS Automation price target lowered to C$52 from C$66 at National Bank 05/18/22 Scotiabank ATS Automation price target lowered to C$53 from C$63 at Scotiabank
Recommendations	Peyto Exploration price target lowered to C$19 from C$19.50 at National Bank » 11:22 08/11/22 08/11 11:22 08/11/22 11:22 PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) 07/18/22 National Bank Peyto Exploration price target lowered to C$19.50 from C$23 at National Bank 07/14/22 Scotiabank Peyto Exploration price target raised to C$24 from C$23 at Scotiabank 06/30/22 Stifel Peyto Exploration price target lowered to C$19.25 from C$20 at Stifel 06/16/22 National Bank Peyto Exploration price target raised to C$23 from C$18 at National Bank

Events

Earnings calls, analyst events, roadshows and more

CCAP
Today at 12:00

Crescent BDC - CCAP Conference Calls
FSM
Today at 12:00

Fortuna Silver Mines - FSM Conference Calls
MNTS
Today at 12:00

Momentus - MNTS Conference Calls
WDAY
Today at 12:00

Technology/Software Industry Meetings
Today at 12:00

Fitmess Industry Meetings
EHC
Today at 12:30

Encompass Health - EHC Conference Calls
Today at 13:00

30-Year Bond Auction Government Event
GWRS
Today at 13:00

Global Water Resources - GWRS Conference Calls
GLNG
Today at 13:00

Golar LNG - GLNG Conference Calls
ACST
Today at 13:00

Acasti Pharma - ACST Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11
Fri	No deals

View All Syndicate Announcements »

FIS files automatic mixed securities shelf

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access